Medical University Graz
Graz, Austria
5 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
Uveal MelanomaChoroidal MelanomaIndeterminate Lesions+1 more
Aura Biosciences100 enrolled71 locationsNCT06007690
Recruiting
Phase 3
Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)
Kidney FailureLiver Failure, ChronicKidney-Pancreas Failure
Dr. F. Köhler Chemie GmbH362 enrolled4 locationsNCT03627013
Recruiting
Phase 3
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
High Risk NeuroblastomaPatient With Insufficient Response Chemoimmunotherapy
Gustave Roussy, Cancer Campus, Grand Paris800 enrolled142 locationsNCT04221035
Recruiting
Not Applicable
Evaluation of Microinvasive Glaucoma Surgery: MINIject® Versus Hydrus® Microstent in Combination With Cataract Surgery
CataractGlaucoma
Medical University of Graz152 enrolled1 locationNCT06844292
Recruiting
Secondary Sclerosis Cholangitis Prospective
Secondary Sclerosis Cholangitis in Critically Ill Patients
Medical University of Graz380 enrolled1 locationNCT03566797